Prognosis Factors for Patients with Stage pT3N0M0 Thoracic Esophageal Squamous Cell Carcinoma after Radical Resection
-
摘要:目的
探讨pT3N0M0期胸段食管鳞癌两野根治术后的预后及其影响因素。
方法胸段食管鳞癌行胸腹两野食管癌根治术后、分期为pT3N0M0者249例，中位年龄60岁（33~78岁）；胸上段39例、胸中段166例、胸下段44例，病变中位长度5 cm（2~12 cm）；术中无粘连者35例、轻度粘连者90例、重度粘连者124例；术中清扫淋巴结中位数9枚（1~27枚）；98例单纯手术、151例行术后辅助治疗。
结果249例中1、3、5年总生存率（overall Survival, OS）和无进展生存率（progression-free survival, PFS）分别为90.0%、68.7%、55.2%和82.1%、61.7%、5 3 . 9%。单因素分析结果显示：性别、肿瘤位置、病理分化程度和术前血红蛋白水平与O S 有关（P<0.05）；年龄、肿瘤位置和术中粘连程度与PFS有关（P<0.05）；多因素分析结果显示：肿瘤位置、术前血红蛋白水平、术前CT有纵隔小淋巴结（<1 cm）和清扫淋巴结数目是OS独立影响因素，肿瘤位置是影响PFS独立危险因素。术后辅助治疗对OS和PFS均无明显影响；但术前CT纵隔有小淋巴结（<1 cm）者，术后辅助治疗可以提高OS和PFS（P<0.05）。
结论pT3N0M0期胸段食管鳞癌胸腹两野根治术后，肿瘤位置影响OS和PFS，胸下段癌预后最好，胸上段癌预后最差；术中清扫淋巴结数多、术前CT纵隔无淋巴结者预后较好，反之预后较差；术前血红蛋白高者生存率低；而术后辅助治疗的价值有待证实。
Abstract:ObjectiveTo evaluate the prognosis and its related factors for the patients with pT3N0M0 thoracic esophageal squamous cell carcinoma (ESCC).
MethodsTwo hundred and forty-nine patients with thoracic ESCC were treated with radical resection and the pathological stage was UICC stage T3N0M0. The median age was 60 years old (range 33-78years). There were 39 cases in the upper-, 166 cases in the middle-, and 44 cases in the lower-thoracic esophagus; the median length of lesion was 5cm (range 2-12cm); as per surgery records, 35, 90 and 124 cases were with none, mild and severe adhesion of surgery, respectively; the median number of removed lymph nodes was 9 (range 1-27) . There were 98 cases with surgery alone and 151 cases with postoperative adjuvant treatment. The statistical analysis used SPSS13.0 statistical software.
ResultsThe 1-, 3-, 5-year overall survival(OS) and progression-free survival(PFS) were 90.0%, 68.7%, 55.2% and 82.1%, 61.7%, 53.9%, respectively. Univariate analysis showed that gender, tumor site, pathological differentiated degree and hemoglobin level before surgery were associated with OS(P<0.05) ; the age, tumor site and adhesion degree during surgery were associated with PFS(P<0.05) . Multivariate analysis showed tumor site, preoperative hemoglobin levels and small mediastinal lymph node(<1cm) in CT before surgery, the number of removed lymph nodes were the independent prognostic factors for OS; tumor site was the only independent factor for PFS. Postoperative adjuvant therapy had not effect on OS or PFS; for patients with small mediastinal lymph node(<1cm) in CT before surgery, the postoperative adjuvant therapy could improve OS and PFS (P<0.05) .
ConclusionFor the patients with stage pT3N0M0 thoracic ESCC treated with radical resection, tumor site is the independent factor for OS and PFS; the prognosis is superior in the upper-, and poor in the lower-ESCC; the prognosis is favorable in the patients who are dissected more lymph nodes at surgery or with out mediastinal lymph node in CT before surgery, and vice verse. The OS is inferior in the patients with high level of hemoglobin before surgery. The value of postoperative adjuvant therapy is needed be proved.
-
Key words:
- Esophageal neoplasm /
- pT3N0M0 /
- Esophagectomy /
- Prognosis
-
-
表 1 pT3N0M0胸段食管鳞癌术后生存单因素分析
Table 1 Univariate analysis on overall survival(OS) of patients with stage pT3N0M0 thoracic ESCC after surgery
下载: 导出CSV
表 2 pT3N0M0胸段食管鳞癌术后生存多因素分析
Table 2 Multivariate analysis on OS of patients with stage pT3N0M0 thoracic ESCC after surgery
下载: 导出CSV
表 3 pT3N0M0胸段ESCC术后无进展生存单因素分析
Table 3 Univariate analysis on progression-free survival(PFS) of patients with stage pT3N0M0 thoracic ESCC after surgery
下载: 导出CSV
表 4 pT3N0M0胸段食管鳞癌术后无进展生存多因素分析
Table 4 Multivariate analysis on PFS of patients with stage pT3N0M0 thoracic ESCC after surgery
下载: 导出CSV
-
[1] Liu W, Hao XS, Jin Y, et al. Analysis of Clinicopathologic Features of Esophageal Cancer Patients after Surgery-a Report of 4, 329 Cases[J]. Zhongguo Zhong Liu Lin Chuang, 2008, 35(5): 24 2-4. [刘巍, 郝郗山, 晋颖, 等. 4329例手术后食管癌临床病理 资料分析[J]. 中国肿瘤临床, 2008, 35(5): 242-4.] [1] 刘巍, 郝郗山, 晋颖, 等. 4329例手术后食管癌临床病理资料分析[J]. 中国肿瘤临床, 2008, 35(5) : 242-4. Liu W, Hao XS, Jin Y, et al. Analysis of Clinicopathologic Features of Esophageal Cancer Patients after Surgery-a Report of 4,329 Cases[J]. Zhongguo Zhong Liu Lin Chuang, 2008, 35(5) : 242-4.
[2] Zhang HL, Liu RL, Shi YT, et al. Analysis of the survival in patients after surgical resection of thoracic esophageal cancer[J]. Zhonghua Zhong Liu Za Zhi, 2009, 31(7): 541-5. [张合林, 刘瑞 林, 石彦涛, 等. 胸段食管癌切除术患者的预后分析[J]. 中华肿 瘤杂志, 2009, 31(7): 541-5.] [2] 张合林, 刘瑞林, 石彦涛, 等. 胸段食管癌切除术患者的预后分析[J]. 中华肿瘤杂志, 2009, 31(7) : 541-5. Zhang HL, Liu RL, Shi YT, et al. Analysis of the survival in patients after surgical resection of thoracic esophageal cancer[J]. Zhonghua Zhong Liu Za Zhi, 2009, 31(7) : 541-5.
[3] Malthaner RA, Wong RK, Rumble RB, et al. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta analysis[J]. BMC Med, 2004, 2: 35.
[3] Malthaner RA, Wong RK, Rumble RB, et al. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta analysis[J]. BMC Med, 2004, 2: 35. [4] Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients[J]. Ann Thorac Surg, 2003, 75(2) : 331-6.
[4] Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients[J]. Ann Thorac Surg, 2003, 75(2): 331-6. [5] Schreiber D, Rineer J, Vongtama D, et al. Impact of postoperative radiation after esophagectomy for esophageal cancer[J]. J Thorac Oncol, 2010, 5(2) : 244-50.
[5] Schreiber D, Rineer J, Vongtama D, et al. Impact of postoperative radiation after esophagectomy for esophageal cancer[J]. J Thorac Oncol, 2010, 5(2): 244-50. [6] Shridhar R, Weber J, Hoffe SE, et al. Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis[J]. J Gastrointest Surg, 2013, 17(8): 1339-45. [6] Shridhar R, Weber J, Hoffe SE, et al. Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis[J]. J Gastrointest Surg, 2013, 17(8) : 1339-45.
[7] 朱卫国, 陶光州, 李涛, 等. 淋巴结阳性的食管癌患者术后预防性放射治疗的回顾性研究[J]. 中华放射医学与防护杂志, 2011, 31(5) : 571-4. Zhu WG, Tao GZ, Li T, et al. Effects of postoperative 3-dimensional conformal radiotherapy on lymph node positive patients after radical resection of esophageal carcinoma[J]. Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi, 2011, 31(5) : 571-4.
[7] Zhu WG, Tao GZ, Li T, et al. Effects of postoperative 3- dimensional conformal radiotherapy on lymph node positive patients after radical resection of esophageal carcinoma[J]. Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi, 2011, 31(5): 57 1-4. [朱卫国, 陶光州, 李涛, 等. 淋巴结阳性的食管癌患者术 后预防性放射治疗的回顾性研究[J]. 中华放射医学与防护杂 志, 2011, 31(5): 571-4.] [8] 刘晓, 章文成, 于舒飞, 等. T2-3 N0 M0期食管癌凡术后失败模式分析术后放疗潜在价值与意义[J]. 中华放射肿瘤学杂志, 2015, 24(1) : 19-24. Liu X, Zhang WC, Yu SF, et al. Patterns of failure after radical surgery among patients vdth stage T2-3 N0 M0 esophageal squamous cell carcinoma-potential value of postoperative radiotherapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2015, 24(1) : 19-24.
[8] Liu X, Zhang WC, Yu SF, et al. Patterns of failure after radical surgery among patients vdth stage T2-3 N0 M0 esophageal squamous cell carcinoma-potential value of postoperative radiotherapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 20 15, 24(1): 19-24. [刘晓, 章文成, 于舒飞, 等. T2-3 N0 M0期食 管癌凡术后失败模式分析术后放疗潜在价值与意义[J]. 中华放 射肿瘤学杂志, 2015, 24(1): 19-24.] [9] Huang WZ, Fu JH, Hu Y, et al. Meta-analysis of Postoperative Adjuvant Chemotherapy for Localized Esophageal Carcinoma[J]. Ai Zheng, 2006, 25(10): 1303-6. [黄伟钊, 傅剑华, 胡祎, 等. 食 管癌术后辅助化疗价值的Meta分析[J]. 癌症, 2006, 25(10): 13 03-6.] [9] 黄伟钊, 傅剑华, 胡祎, 等. 食管癌术后辅助化疗价值的Meta分析[J]. 癌症, 2006, 25(10) : 1303-6. Huang WZ, Fu JH, Hu Y, et al. Meta-analysis of Postoperative Adjuvant Chemotherapy for Localized Esophageal Carcinoma[J]. Ai Zheng, 2006, 25(10) : 1303-6.
[10] 张杰, 陈海泉, 张亚伟, 等. 食管癌术后辅助化疗的荟萃分析和来自复旦大学附属肿瘤医院的配对研究[J]. 中国癌症杂志, 2008, 18(4) : 276-81. Zhang J, Chen HQ, Zhang YW, et al. Adjuvant chemotherapy in esophageal cancer: a meta-analysis and experience from Cancer Hospital, Fudan University[J]. Zhongguo Ai Zheng Za Zhi, 2008, 18(4) : 276-81.
[10] Zhang J, Chen HQ, Zhang YW, et al. Adjuvant chemotherapy in esophageal cancer: a meta-analysis and experience from Cancer Hospital, Fudan University[J]. Zhongguo Ai Zheng Za Zhi, 2008, 18 (4): 276-81. [张杰, 陈海泉, 张亚伟, 等. 食管癌术后辅助化疗 的荟萃分析和来自复旦大学附属肿瘤医院的配对研究[J]. 中国 癌症杂志, 2008, 18(4): 276-81.] [11] Lv X, Huang J. Current status of postoperative adjuvant therapy in esophageal squamous cell carcinoma[J]. Ai Zheng Jin Zhan, 20 13, 11(4): 314-8. [吕潇, 黄镜. 食管鳞癌术后辅助治疗现状[J]. 癌症进展, 2013, 11(4): 314-8.] [11] 吕潇, 黄镜. 食管鳞癌术后辅助治疗现状[J]. 癌症进展, 2013, 11(4) : 314-8. Lv X, Huang J. Current status of postoperative adjuvant therapy in esophageal squamous cell carcinoma[J]. Ai Zheng Jin Zhan, 2013, 11(4) : 314-8.
[12] Zhu SC, Song CL, Shen WB, et al. Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma[J]. Zhonghua Zhong Liu Za Zhi, 2012, 34 (4): 281-6. [祝淑钗, 宋长亮, 沈文斌, 等. 食管癌根治性切除 术后患者预后的影响因素分析[J]. 中华肿瘤杂志, 2012, 34(4): 28 1-6.] [12] 祝淑钗, 宋长亮, 沈文斌, 等. 食管癌根治性切除术后患者预后的影响因素分析[J]. 中华肿瘤杂志, 2012, 34(4) : 281-6. Zhu SC, Song CL, Shen WB, et al. Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma[J]. Zhonghua Zhong Liu Za Zhi, 2012, 34(4) : 281-6.
[13] Zhang DK, Su XD, Lin P, et al. Survival Analysis of Patients with Stage Ⅱ Squamous Cell Carcinoma of the Thoracic Esophagus after esophagectomy[J]. Ai Zheng, 2008, 27(2): 113-8. [张冬坤, 苏晓东, 林鹏, 等. 467例Ⅱ期胸段食管鳞癌切除术后患者的生 存分析[J]. 癌症, 2008, 27(2): 113-8.] [13] 张冬坤, 苏晓东, 林鹏, 等. 467例Ⅱ期胸段食管鳞癌切除术后患者的生存分析[J]. 癌症, 2008, 27(2) : 113-8. Zhang DK, Su XD, Lin P, et al. Survival Analysis of Patients with Stage Ⅱ Squamous Cell Carcinoma of the Thoracic Esophagus after esophagectomy[J]. Ai Zheng, 2008, 27(2) : 113-8.
[14] 张明月, 王洲, 刘相燕, 等. Ivor-Lewis手术辅助放疗对ⅡA期中段食管癌局部控制的临床研究[J]. 中华外科杂志, 2008, 46(14) : 1048-50. Zhang MY, Wang Z, Liu XY, et al. The local control of radiotherappy following Ivor-Lewis esophagectomy in the patients with stage ⅡA middli-third thoracic esophageal cancer[J]. Zhonghua Wai Ke Za Zhi, 2008, 46(14) : 1048-50.
[14] Zhang MY, Wang Z, Liu XY, et al. The local control of radiotherappy following Ivor-Lewis esophagectomy in the patients with stage ⅡA middli-third thoracic esophageal cancer[J]. Zhonghua Wai Ke Za Zhi, 2008, 46(14): 1048-50. [张明月, 王洲, 刘相燕, 等. Ivor-Lewis手术辅助放疗对ⅡA期中段食管癌局部 控制的临床研究[J]. 中华外科杂志, 2008, 46(14): 1048-50.] [15] An FS, Huang JQ, Chen SH. AnaIysis of lymph node metastases of 217 cases of thoracic esophageaI carcinoma and its impact on prognosis[J]. Ai Zheng, 2003, 22(9): 974-7. [安丰山, 黄金球, 陈 少湖. 217例胸段食管癌淋巴结转移及其对预后影响的分析[J]. 癌症, 2003, 22(9): 974-7.] [15] 安丰山, 黄金球, 陈少湖. 217例胸段食管癌淋巴结转移及其对预后影响的分析[J]. 癌症, 2003, 22(9) : 974-7. An FS, Huang JQ, Chen SH. AnaIysis of lymph node metastases of 217 cases of thoracic esophageaI carcinoma and its impact on prognosis[J]. Ai Zheng, 2003, 22(9) : 974-7.
[16] Chen J, Zhu J, Pan J, et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus[J]. Ann Thorac Surg, 2010, 90(2): 435-42. [16] Chen J, Zhu J, Pan J, et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus[J]. Ann Thorac Surg, 2010, 90(2) : 435-42.
[17] Yang HX, Xu Y, Fu JH, et al. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma:data from China[J]. Ann Surg Oncol, 2010, 17(7) : 1901-11.
[17] Yang HX, Xu Y, Fu JH, et al. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma:data from China[J]. Ann Surg Oncol, 2010, 17(7): 19 01-11. [18] Groth SS, Virnig BA, Whitson BA, et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database[J]. J Thorac Cardiovasc Surg, 2010, 139(3) : 612-20.
[18] Groth SS, Virnig BA, Whitson BA, et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database[J]. J Thorac Cardiovasc Surg, 2010, 139(3): 612-20. [19] Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph nodenegative esophageal cancer[J]. Cancer, 2008, 112(6): 1239-46. [19] Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph nodenegative esophageal cancer[J]. Cancer, 2008, 112(6) : 1239-46.
[20] 解明然, 梅新宇, 李田, 等. 阴性淋巴结数目对无淋巴结转移食管鳞癌患者预后的影响[J]. 中华胸心血管外科杂志, 2014, 30(4) : 221-4. Xie MR, Mei XY, Li T, et al. The prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis after esophagectomy[J]. Zhonghua Xiong Xin Xue Guan Wai Ke Za Zhi, 2014, 30(4) : 221-4.
[20] Xie MR, Mei XY, Li T, et al. The prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis after esophagectomy[J]. Zhonghua Xiong Xin Xue Guan Wai Ke Za Zhi, 2014, 30(4): 221-4. [解明然, 梅新 宇, 李田, 等. 阴性淋巴结数目对无淋巴结转移食管鳞癌患者预 后的影响[J]. 中华胸心血管外科杂志, 2014, 30(4): 221-4.] [21] Chen LQ, Hu CY, Zhang HL, et al. Influence of removed lymph nodes on the TNM stage and survival in advanced esophageal carcinoma[J]. Zhonghua Zhong Liu Za Zhi, 2007, 29(8): 604-8. [陈龙奇, 胡春燕, 张合林, 等. 淋巴结清扫数目对进展期食管癌 TNM分期和预后的影响[J]. 中华肿瘤杂志, 2007, 29(8): 604-8.] [21] 陈龙奇, 胡春燕, 张合林, 等. 淋巴结清扫数目对进展期食管癌 TNM分期和预后的影响[J]. 中华肿瘤杂志, 2007, 29(8) : 604-8. Chen LQ, Hu CY, Zhang HL, et al. Influence of removed lymph nodes on the TNM stage and survival in advanced esophageal carcinoma[J]. Zhonghua Zhong Liu Za Zhi, 2007, 29(8) : 604-8.
[22] Xu Y, Liu J, Du X, et al. Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer[J]. Radiat Oncol, 2013, 8: 116.
[22] Xu Y, Liu J, Du X, et al. Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer[J]. Radiat Oncol, 2013, 8: 116. [23] Su XD, Zhang DK, Zhang X, et al. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma[J]. J Thorac Dis, 2014, 6(7): 949-57. [23] Su XD, Zhang DK, Zhang X, et al. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma[J]. J Thorac Dis, 2014, 6(7) : 949-57.
[24] Liu Q, Cai XW, Wu B, et al. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy[J]. PLoS One, 2014, 9(5): e97225. [24] Liu Q, Cai XW, Wu B, et al. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy[J]. PLoS One, 2014, 9(5) : e97225.
[25] Guo XF, Mao T, Gu ZT, et al. Clinical study on postoperativ e recurrence in patients with pN0 esophageal squamous cell carcinoma[J]. J Cardiothorac Surg, 2014, 9: 150. [25] Guo XF, Mao T, Gu ZT, et al. Clinical study on postoperativ e recurrence in patients with pN0 esophageal squamous cell carcinoma[J]. J Cardiothorac Surg, 2014, 9: 150.
[26] Ma r i e t t e C, Ba l o n JM, P i e s s e n G, e t a l . P a t t e r n of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease[J]. Cancer, 20 03, 97(7): 1616-23. [26] Mariette C, Balon JM, Piessen G, et al . Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease[J]. Cancer, 2003, 97(7) : 1616-23.
[27] Liu J, Lv CX, Wang JM, et al. Pattern of relapse in left thoracotomy surgical treated patients with thoracic esophageal cancer and their value in target region delineation in postoperative radiotherapy[J]. Zhonghua Fang She Zhong Liu Za Zhi, 2013, 22 (2): 111-4. [刘俊, 吕长兴, 王家明, 等. 104例胸段食管癌左胸 路径术后局部复发规律及放疗靶区范围探讨[J]. 中华放射肿瘤 杂志, 2013, 22(2): 111-4.] [27] 刘俊, 吕长兴, 王家明, 等. 104例胸段食管癌左胸路径术后局部复发规律及放疗靶区范围探讨[J]. 中华放射肿瘤杂志, 2013, 22(2) : 111-4. Liu J, Lv CX, Wang JM, et al. Pattern of relapse in left thoracotomy surgical treated patients with thoracic esophageal cancer and their value in target region delineation in postoperative radiotherapy[J]. Zhonghua Fang She Zhong Liu Za Zhi, 2013, 22(2) : 111-4.
[28] Zhang HQ, Wang RB, Yan HJ, et al. Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy[J]. Asian Pac J Cancer Prev, 2012, 13(1) : 199-203.
[28] Zhang HQ, Wang RB, Yan HJ, et al. Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy[J]. Asian Pac J Cancer Prev, 2012, 13(1): 199-203. [29] Hamai Y, Hihara J, Taomoto J, et al. Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy foresophageal squamous cell carcinoma[J]. World J Surg, 2014, 38 (8): 2046-51. [29] Hamai Y, Hihara J, Taomoto J, et al. Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy foresophageal squamous cell carcinoma[J]. World J Surg, 2014, 38(8) : 2046-51.
[30] Rades D, Schild SE, Bahrehmand R, et al. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels[J]. Cancer, 2005, 103(8) : 1740-6.
[30] Rades D, Schild SE, Bahrehmand R, et al. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels[J]. Cancer, 2005, 103(8): 1740-6. [31] Valencia Julve J, Alonso Orduña V, Escó Barón R, et al. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy[J]. Clin Transl Oncol, 20 06, 8(1): 22-30. [31] Valencia Julve J, Alonso Orduña V, Escó Barón R, et al. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy[J]. Clin Transl Oncol, 2006, 8(1) : 22-30.
计量
- 文章访问数: 1473
- HTML全文浏览量: 328
- PDF下载量: 309
